Radical prostatectomy-which patients benefit most from surgery?

Affiliations

Editorial

Joseph A Smith Jr. J Urol. 2006 Aug.

. 2006 Aug;176(2):437.

doi: 10.1016/j.juro.2006.05.019.

No abstract available

Comment on

Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, Freedland SJ. Makarov DV, et al. J Urol. 2006 Aug;176(2):554-8. doi: 10.1016/j.juro.2006.03.058. J Urol. 2006. PMID: 16813888
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
Porter CR, Kodama K, Gibbons RP, Correa R Jr, Chun FK, Perrotte P, Karakiewicz PI. Porter CR, et al. J Urol. 2006 Aug;176(2):569-74. doi: 10.1016/j.juro.2006.03.094. J Urol. 2006. PMID: 16813891